Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CUREs in biochemistry-where we are and where we should go.

ABSTRACT: Integration of research experience into classroom is an important and vital experience for all undergraduates. These course-based undergraduate research experiences (CUREs) have grown from independent instructor lead projects to large consortium driven experiences. The impact and importance of CUREs on students at all levels in biochemistry was the focus of a National Science Foundation funded think tank. The state of biochemistry CUREs and suggestions for moving biochemistry forward as well as a practical guide (supplementary material) are reported here. © 2016 by The International Union of Biochemistry and Molecular Biology, 45(1):7-12, 2017.

SUBMITTER: Bell JK

PROVIDER: S-EPMC5297992 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

CUREs in biochemistry-where we are and where we should go.

Bell Jessica K JK Eckdahl Todd T TT Hecht David A DA Killion Patrick J PJ Latzer Joachim J Mans Tamara L TL Provost Joseph J JJ Rakus John F JF Siebrasse Erica A EA Ellis Bell J J

Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology 20160630 1

Integration of research experience into classroom is an important and vital experience for all undergraduates. These course-based undergraduate research experiences (CUREs) have grown from independent instructor lead projects to large consortium driven experiences. The impact and importance of CUREs on students at all levels in biochemistry was the focus of a National Science Foundation funded think tank. The state of biochemistry CUREs and suggestions for moving biochemistry forward as well as ...[more]

PMID: 27357379

Similar Datasets

Ganglioside biochemistry.

Project description:Gangliosides are sialic acid-containing glycosphingolipids. They occur especially on the cellular surfaces of neuronal cells, where they form a complex pattern, but are also found in many other cell types. The paper provides a general overview on their structures, occurrence, and metabolism. Key functional, biochemical, and pathobiochemical aspects are summarized.

| S-EPMC4393008 | biostudies-literature

Biochemistry of spontaneous preterm birth

Project description:Transcriptome analysis of preterm and term placentas

2021-08-10 | GSE120480 | GEO

Finding promising cures for migraine: targeting neuropeptides.

Project description: Not available

| S-EPMC7838043 | biostudies-literature

Evolving AAV-delivered therapeutics towards ultimate cures.

Project description:Gene therapy has entered a new era after decades-long efforts, where the recombinant adeno-associated virus (AAV) has stood out as the most potent vector for in vivo gene transfer and demonstrated excellent efficacy and safety profiles in numerous preclinical and clinical studies. Since the first AAV-derived therapeutics Glybera was approved by the European Medicines Agency (EMA) in 2012, there is an increasing number of AAV-based gene augmentation therapies that have been developed and tested for treating incurable genetic diseases. In the subsequent years, the United States Food and Drug Administration (FDA) approved two additional AAV gene therapy products, Luxturna and Zolgensma, to be launched into the market. Recent breakthroughs in genome editing tools and the combined use with AAV vectors have introduced new therapeutic modalities using somatic gene editing strategies. The promising outcomes from preclinical studies have prompted the continuous evolution of AAV-delivered therapeutics and broadened the scope of treatment options for untreatable diseases. Here, we describe the clinical updates of AAV gene therapies and the latest development using AAV to deliver the CRISPR components as gene editing therapeutics. We also discuss the major challenges and safety concerns associated with AAV delivery and CRISPR therapeutics, and highlight the recent achievement and toxicity issues reported from clinical applications.

| S-EPMC7885987 | biostudies-literature

VNI cures acute and chronic experimental Chagas disease.

Project description:Chagas disease is a deadly infection caused by the protozoan parasite Trypanosoma cruzi. Afflicting approximately 8 million people in Latin America, Chagas disease is now becoming a serious global health problem proliferating beyond the traditional geographical borders, mainly because of human and vector migration. Because the disease is endemic in low-resource areas, industrial drug development has been lethargic. The chronic form remains incurable, there are no vaccines, and 2 existing drugs for the acute form are toxic and have low efficacy. Here we report the efficacy of a small molecule, VNI, including evidence of its effectiveness against chronic Chagas disease. VNI is a potent experimental inhibitor of T. cruzi sterol 14?-demethylase. Nontoxic and highly selective, VNI displays promising pharmacokinetics and administered orally to mice at 25 mg/kg for 30 days cures, with 100% cure rate and 100% survival, the acute and chronic T. cruzi infection.

| S-EPMC3698996 | biostudies-literature

Arnica Tincture Cures Cutaneous Leishmaniasis in Golden Hamsters.

Project description:In search for potential therapeutic alternatives to existing treatments for cutaneous Leishmaniasis, we have investigated the effect of Arnica tincture Ph. Eur. (a 70% hydroethanolic tincture prepared from flowerheads of Arnica montana L.) on the lesions caused by infection with Leishmania braziliensis in a model with golden hamsters. The animals were treated topically with a daily single dose of the preparation for 28 days. Subsequently, the healing process was monitored by recording the lesion size in intervals of 15 days up to day 90. As a result, Arnica tincture fully cured three out of five hamsters while one animal showed an improvement and another one suffered from a relapse. This result was slightly better than that obtained with the positive control, meglumine antimonate, which cured two of five hamsters while the other three showed a relapse after 90 days. This result encourages us to further investigate the potential of Arnica tincture in the treatment of cutaneous Leishmaniasis.

| S-EPMC6017635 | biostudies-literature

GO-ACTIWE

Project description:Structured exercise alters the gut microbiota in healthy humans with overweight and obesity – a randomized controlled trial

| PRJEB33268 | ENA

Personalized biochemistry and biophysics.

Project description:Whole human genome sequencing of individuals is becoming rapid and inexpensive, enabling new strategies for using personal genome information to help diagnose, treat, and even prevent human disorders for which genetic variations are causative or are known to be risk factors. Many of the exploding number of newly discovered genetic variations alter the structure, function, dynamics, stability, and/or interactions of specific proteins and RNA molecules. Accordingly, there are a host of opportunities for biochemists and biophysicists to participate in (1) developing tools to allow accurate and sometimes medically actionable assessment of the potential pathogenicity of individual variations and (2) establishing the mechanistic linkage between pathogenic variations and their physiological consequences, providing a rational basis for treatment or preventive care. In this review, we provide an overview of these opportunities and their associated challenges in light of the current status of genomic science and personalized medicine, the latter often termed precision medicine.

| S-EPMC4415889 | biostudies-literature

A model of the go/no-go task.

Project description:In this article, the first explicit, theory-based comparison of 2-choice and go/no-go variants of 3 experimental tasks is presented. Prior research has questioned whether the underlying core-information processing is different for the 2 variants of a task or whether they differ mostly in response demands. The authors examined 4 different diffusion models for the go/no-go variant of each task along with a standard diffusion model for the 2-choice variant (R. Ratcliff, 1978). The 2-choice and the go/no-go models were fit to data from 4 lexical decision experiments, 1 numerosity discrimination experiment, and 1 recognition memory experiment, each with 2-choice and go/no-go variants. The models that assumed an implicit decision criterion for no-go responses produced better fits than models that did not. The best model was one in which only response criteria and the nondecisional components of processing changed between the 2 variants, supporting the view that the core information on which decisions are based is not different between them.

| S-EPMC2701630 | biostudies-literature

Biochemistry of spontaneous preterm birth

Project description:Biochemistry of spontaneous preterm birth

| PRJNA493125 | ENA